Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Done

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Breast Cancer Research : BCR|July 6, 2014
Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populationsDong-Yu Wang, Susan J Done, David R Mc Cready, et al.
Nuclear Medicine and Biology|December 3, 2014
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumabKaren Lam, Conrad Chan, Susan J Done, et al.
International Journal of Cancer|December 23, 2014
Identification of genomic signatures in circulating tumor cells from breast cancerNisha Kanwar, Pingzhao Hu, Philippe Bedard, et al.
British Journal of Cancer|April 15, 2026
TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progressionDong-Yu Wang, Zhe Jiang, Yaacov Ben-David, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 20, 2010
Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situDeborah Williamson, Robert Dinniwell, Sharon Fung, et al.
Archives of Pathology & Laboratory Medicine|July 8, 2022
Resident Depression and Burnout During the COVID-19 Pandemic: A Survey of Canadian Laboratory Medicine TraineesRachel Han, Elan Hahn, Susan J Done, et al.
Journal of Pathology Informatics|March 4, 2022
MiNuGAN: Dual Segmentation of Mitoses and Nuclei Using Conditional GANs on Multi-center Breast H&E ImagesSalar Razavi, Fariba D Khameneh, Hana Nouri, et al.
Scientific Reports|October 21, 2025
Lightweight self supervised learning framework for domain generalization in histopathologyAbubakr Shafique, Amanda Dy, Xiaoli Qin, et al.
Journal of Clinical Pathology|July 9, 2018
Breast tumour resembling tall cell variant of papillary thyroid carcinoma: case presentation (in a patient with Lynch syndrome)Luis Gai, Susan J Done, Donald Cook, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2008
Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenograftsKristin McLarty, Bart Cornelissen, Deborah A Scollard, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Breast Cancer Research : BCR|July 6, 2014
Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populationsDong-Yu Wang, Susan J Done, David R Mc Cready, et al.
Nuclear Medicine and Biology|December 3, 2014
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumabKaren Lam, Conrad Chan, Susan J Done, et al.
International Journal of Cancer|December 23, 2014
Identification of genomic signatures in circulating tumor cells from breast cancerNisha Kanwar, Pingzhao Hu, Philippe Bedard, et al.
British Journal of Cancer|April 15, 2026
TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progressionDong-Yu Wang, Zhe Jiang, Yaacov Ben-David, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 20, 2010
Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situDeborah Williamson, Robert Dinniwell, Sharon Fung, et al.
Archives of Pathology & Laboratory Medicine|July 8, 2022
Resident Depression and Burnout During the COVID-19 Pandemic: A Survey of Canadian Laboratory Medicine TraineesRachel Han, Elan Hahn, Susan J Done, et al.
Journal of Pathology Informatics|March 4, 2022
MiNuGAN: Dual Segmentation of Mitoses and Nuclei Using Conditional GANs on Multi-center Breast H&E ImagesSalar Razavi, Fariba D Khameneh, Hana Nouri, et al.
Scientific Reports|October 21, 2025
Lightweight self supervised learning framework for domain generalization in histopathologyAbubakr Shafique, Amanda Dy, Xiaoli Qin, et al.
Journal of Clinical Pathology|July 9, 2018
Breast tumour resembling tall cell variant of papillary thyroid carcinoma: case presentation (in a patient with Lynch syndrome)Luis Gai, Susan J Done, Donald Cook, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 21, 2008
Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenograftsKristin McLarty, Bart Cornelissen, Deborah A Scollard, et al.
Pageof 9